US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Truscreen Group Limited (TRU) 銘柄情報

Truscreen Group Limited (TRU)

0.016

0.00

( 0.00% )

更新日時： 09:00:05

Truscreen Group Limited (TRU) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.016

( - )

買値

0.015

売値

0.016

出来高

8,741

0.016 日の範囲 0.016

0.012 52 週間の範囲 0.025

時価総額

前日終値

0.016

始値

0.016

時刻

最終取引時間

09:00:05

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 506,564

発行済株式数

747,325,326

配当利回り

PER

-5.91

1 株当たり利益 (EPS)

-0

歳入

2.82M

純利益

-2.25M

TruScreen Group Limited, together with its subsidiaries, develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, and the Middle East/North Africa. It offers the TruScreen cervical cancer screening device, a medical device for identifying a... TruScreen Group Limited, together with its subsidiaries, develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, and the Middle East/North Africa. It offers the TruScreen cervical cancer screening device, a medical device for identifying and detecting the presence of precancerous and cancerous tissue on the cervix in real time. The company was formerly known as TruScreen Limited and changed its name to Truscreen Group Limited in August 2020. TruScreen Group Limited was incorporated in 2013 and is headquartered in Auckland, New Zealand. 詳細を表示

セクター

Healthcare

業界

Medical Equipment & Supplies

ウェブサイト

truscreen.com

本社

Auckland, New Zealand

設立

2026

Truscreen Group Limited is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker TRU. The last closing price for Truscreen was AUD0.02. Over the last year, Truscreen shares have traded in a share price range of AUD 0.012 to AUD 0.025.

Truscreen currently has 747,325,326 shares in issue. The market capitalisation of Truscreen is AUD11.96 million. Truscreen has a price to earnings ratio (PE ratio) of -5.91.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0.016	0.018	0.015	2937567	0.01650405	DE
4	0.001	6.66666666667	0.015	0.018	0.012	2684997	0.01646908	DE
12	0.003	23.0769230769	0.013	0.018	0.012	1061907	0.01615349	DE
26	0	0	0.016	0.025	0.012	898551	0.01636762	DE
52	-0.002	-11.1111111111	0.018	0.025	0.012	623931	0.01657085	DE
156	-0.013	-44.8275862069	0.029	0.033	0.012	344732	0.01781464	DE
260	-0.057	-78.0821917808	0.073	0.1075	0.012	306355	0.03301938	DE

TRU - Frequently Asked Questions (FAQ)

What is the current Truscreen Group Limited share price?

The current share price of Truscreen Group Limited is AUD 0.016

How many Truscreen Group Limited shares are in issue?

Truscreen Group Limited has 747,325,326 shares in issue

What is the market cap of Truscreen Group Limited?

The market capitalisation of Truscreen Group Limited is AUD 11.96M

What is the 1 year trading range for Truscreen Group Limited share price?

Truscreen Group Limited has traded in the range of AUD 0.012 to AUD 0.025 during the past year

What is the PE ratio of Truscreen Group Limited?

The price to earnings ratio of Truscreen Group Limited is -5.91

What is the cash to sales ratio of Truscreen Group Limited?

The cash to sales ratio of Truscreen Group Limited is 5.03

What is the registered address of Truscreen Group Limited?

The registered address for Truscreen Group Limited is Equitable House, Auckland, 1010

What is the Truscreen Group Limited website address?

The website address for Truscreen Group Limited is truscreen.com

Which industry sector does Truscreen Group Limited operate in?

Truscreen Group Limited operates in the Medical Equipment & Supplies sector

Duke Knockem

Duke Knockem 4分前

alright well go on Twitter and make a judge Judy of yourself man there only OTC retards on here and that includes myself

floblu14

floblu14 6分前

Addendum - from AI
Hearing Date: The UPC hearing is set for September 29, 2026, with a decision anticipated from the court within weeks following the hearing.

Mistervane

Mistervane 6分前

Not an obituary. Still speculation. “I’m hearing…” is not factual information.

Fangster

Fangster 7分前

Excellent find, Yoda! Great potential connection direct to the president.

satter

I am not sure how the silver mine deal proceeds or others.

Since Hiru never posted a bond the plaintiff could have gone after assets at any time. I was surprised there was no prior activity. It appears they were either waiting for the appeal to conclude or doing investigative work.

ErnieBilco

ErnieBilco 8分前

Scinai Immunotherapeutics Ltd.
Jerusalem BioPark, 2nd Floor
Hadassah Ein Kerem Campus
Jerusalem
Israel

www.scinai.com

Cheef Zed

Cheef Zed 8分前

Interesting action lately … need some updates from company !!

ErnieBilco

ErnieBilco 9分前

Scinai Immunotherapeutics Ltd. is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products primarily for the treatment of autoimmune and infectious diseases.

peafunke

peafunke 10分前

Good… I’ll keep buying.

Duke Knockem

Duke Knockem 10分前

https://x.com/i/status/2063989669667180674

Duke Knockem

Duke Knockem 10分前

https://x.com/i/status/2063989669667180674

17yearsnomoney

17yearsnomoney 10分前

I try to post on the RKT board however if you dare to call out the liars and misinformation that’s been posted for 17 years you end up here.

Crapola2theleft

Crapola2theleft 11分前

Sure sounds like projection !

JTORENCE

JTORENCE 11分前

brooktrail1933 The U.K. is not a big fan of the U.S. Add to that there are more than 5 million Muslims living in the U.K. Could one guess that at least 25% are anti American? Of those 25%, how many does the MHRA employ?
NWBO is a US company. Doesn't take much of an imagination to see th

biosectinvestor

biosectinvestor 12分前

I agree 100% Chiugray. They can whistleblow on their peers and who they are working with and way many, many times what they are now, likely a fortune, IMHO. Have a wonderful day!

floblu14

floblu14 13分前

There is an upcoming public oral hearing scheduled in Enanta Pharmaceuticals' European patent infringement case against Pfizer over the COVID-19 antiviral drug Paxlovid.

The Unified Patent Court (UPC) of the European Union has scheduled the hearing for September 29, 2026.Case Details:

mascale

mascale 15分前

Satter claim that USA has no courts(?): not literacy.

Arturosurfer

Arturosurfer 16分前

If I sold it would cost more for the fees than it’s worth unfortunately.

Denn55

Denn55 16分前

I looked everywhere but only found the headline. I dont think there is anything else yet. I guess its coming soon.

OMOLIVES

OMOLIVES 17分前

Hopefully that's not the case. He would be way too young for that.

biosectinvestor

biosectinvestor 17分前

You are repeating the same claims, but repetition is not evidence.

The FDA sentence you keep quoting addresses a specific concern: selecting an external control arm after completing a single-arm trial. DCVax-L was not a completed single-arm trial. JAMA Oncology states directly: “This

Duke Knockem

Duke Knockem 18分前

de large, Falcon, etc all the big bag holders from George Sharp that have been blocked,I know what their game is

Mistervane

Mistervane 18分前

Still no obituary.

quigley24

quigley24 19分前

Duke Knockem

Duke Knockem 20分前

I know that I have made my research, I have been taking screenshot of all the person's claiming his death on Twitter and if George is not deceased everyone will be facing legal charges

iShares MSCI World CTB E...

Ci Canadian Bond Fund Cl...

Flt Rte Grn Bnds 25/10/29

EO-Medium-Term Nts 2015(...

WisdomTree Commodity Sec...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。